Association between up‐titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrum
Vasiliki Bistola(National and Kapodistrian University of Athens), Gerasimos Filippatos(National and Kapodistrian University of Athens), Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), Wouter Ouwerkerk(University of Amsterdam), Effie Polyzogopoulou(National and Kapodistrian University of Athens), Marco Metra(Vita-Salute San Raffaele University), Dimitrios Farmakis(National and Kapodistrian University of Athens), Adriaan A. Voors(University Medical Center Groningen), John Parissis(National and Kapodistrian University of Athens), Kalliopi Keramida(National and Kapodistrian University of Athens), Nilesh J. Samani(University of Leicester), Stefan D. Anker(Charité - Universitätsmedizin Berlin), Panagiotis Simitsis(National and Kapodistrian University of Athens), Dirk J. van Veldhuisen(University Medical Center Groningen), John G.F. Cleland(University of Glasgow)
Cited by 16
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k